Drug repurposing and discovery multidisciplinary training network

Project Information

DRUGtrain

Grant agreement ID: 955879

DOI

10.3030/955879

Project closed

EC signature date 16 July 2020

Start date 1 January 2021

End date 31 December 2024

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 2 394 816,84

EU contribution

€ 2 394 816,84

Coordinated by

ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Other (4)

Presentations and publications

Presentations at international meetings and articles for peer review journals and/or theses.The reporting period of this deliverable will cover the period from mo 12 to mo 48.

Network meetings - dissemination

Organisation of dissemination session at network meetings.The reporting period of this deliverable will cover the period from mo 10 to mo 46.

Dissemination, communication and IP activities

Reporting on dissemination, communication and IP activities.The reporting period of this deliverable will cover the period from mo 12 to mo 48.

Presentation/activities at open days, student fairs, (social) media

Presentation/activities at open days, student fairs, (social) media.The reporting period of this deliverable will cover the period from mo 6 to mo 46.

Websites, patent fillings, videos etc. (1)

Launch of DRUGtrain website and twitter account

Launch of DRUGtrain website and twitter account established

Documents, reports (1)

Patient derived 3D organoid culture

Report on patient derived 3D organoid culture

Publications

Peer reviewed articles (4)

Albumin-Mediated Drug Uptake by Organic Anion Transporter 1/3 Is Real: Implications for the Prediction of Active Renal Secretion Clearance

Author(s): Shawn Pei Feng Tan, Annika Tillmann, Susan J. Murby, Amin Rostami-Hodjegan, Daniel Scotcher, Aleksandra Galetin
Published in: Molecular Pharmaceutics, Issue 21, 2024, Page(s) 4603-4617, ISSN 1543-8384
Publisher: American Chemical Society
DOI: 10.1021/acs.molpharmaceut.4c00504

QSPRpred: a Flexible Open-Source Quantitative Structure-Property Relationship Modelling Tool

Author(s): Helle W. van den Maagdenberg, Martin Šícho, David Alencar Araripe, Sohvi Luukkonen, Linde Schoenmaker, Michiel Jespers, Olivier J. M. Béquignon, Marina Gorostiola González, Remco L. van den Broek, Andrius Bernatavicius, J. G. Coen van Hasselt, Piet. H. van der Graaf, Gerard J. P. van Westen
Published in: Journal of Cheminformatics, Issue 16, 2024, ISSN 1758-2946
Publisher: Chemistry Central
DOI: 10.1186/s13321-024-00908-y

Label-free but still constrained: Assessment of global proteomic strategies for the quantification of hepatic enzymes and transporters

Author(s): Barber J, Al-Majdoub ZM, Couto N, Vasilogianni AM, Tillmann A, Alrubia S, Rostami-Hodjegan A, Achour B.
Published in: Drug metabolism and disposition, Issue 50, 2022, Page(s) 762-769, ISSN 0090-9556
Publisher: American Society for Pharmacology and Experimental Therapeutics
DOI: 10.1124/dmd.121.000780

Targeting Kidney Fibrosis with Polymeric Nanocarriers

Author(s): Vedangi Kulkarni, Tim Caspers, Diana Moeckel, Susanne Koletnik, Elena Rama, Paraskevi Sotiropoulou, Daniel R. Dietrich, Robert Pola, Lenka Kotrchová, Tomáš Etrych, Yvonne H. W. Derks, Peter Boor, Fabian Kiessling, Felix M. Mottaghy, Barbara M. Klinkhammer, Twan Lammers
Published in: Chemistry of Materials, Issue 36, 2024, Page(s) 9686-9695, ISSN 0897-4756
Publisher: American Chemical Society
DOI: 10.1021/acs.chemmater.4c01788